Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy

Inclusion Criteria: * Male or female healthy subjects, 18-45 years of age and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening. * Female subjects must have been surgically sterilized at least six months prior to screening. Surgical sterilization procedures must be supported with clinical documentation made available to the sponsor and noted in the Relevant Medical History / Current Medical Conditions section of the CRF. OR: Postmenopausal women must have no regular menstrual bleeding for at least two years prior to inclusion. Menopause was to be confirmed by a plasma 17β-estradiol concentration of \<20 pg/mL and a plasma FSH level of \>40 IU/L. * Normal sitting blood pressure and pulse rate , i.e.: BP: 100 - 140 mm Hg systolic, 50 - 90 mm Hg diastolic and pulse rate: 45 - 100 bpm. Blood pressure and pulse were to be measured after 3 minutes resting in a sitting position. * Subject body mass index between 18 and 30 kg/m2 * Ability to communicate well with the investigator and comply with the requirements of the entire study. * The subject has given his written consent to participate in the study. Exclusion Criteria: * History of serious adverse reactions or hypersensitivity to any drug. * Presence or history of any allergy requiring acute or chronic treatment (seasonal) allergic rhinitis which requires no treatment may be tolerated). * History of alcohol or drug abuse in the last 3 …